{
  "title": "Special Considerations",
  "populations": [
    {
      "group": "Children and Adolescents",
      "description": "Evidence for effective treatment of migraine is weaker in children than in adults. Three triptans are approved by the U.S Food and Drug Administration for use in this population: almotriptan, rizatriptan, and sumatriptan in combination with naproxen."
    },
    {
      "group": "Pregnancy and Lactation",
      "description": "Acetaminophen and metoclopramide are the only treatments for migraine considered safe in pregnancy. Although controversial, triptans can be considered for use in pregnant women with debilitating migraines."
    },
    {
      "group": "Contraindications to Vasoconstrictors",
      "description": "Triptans and other vasoconstrictors are contraindicated in patients with coronary artery disease and in specific migraine syndromes. Nonopioid combination analgesics, especially acetaminophen/aspirin/caffeine, are most helpful in these conditions."
    }
  ]
}
